ArticleCancer reports (Hoboken, N.J.)2023

Plasma progastrin-releasing peptide level shows different predictive profiles for treatment response by androgen receptor axis-targeted agents in patients with metastatic castration-resistant prostate cancer.

Masahiro Yashi et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.